China
· Delayed Price · Currency is CNY Intco Medical Technology Statistics
Total Valuation
Intco Medical Technology has a market cap or net worth of CNY 16.90 billion. The enterprise value is 11.53 billion.
| Market Cap | 16.90B |
| Enterprise Value | 11.53B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | May 31, 2024 |
Share Statistics
Intco Medical Technology has 643.40 million shares outstanding. The number of shares has decreased by -1.83% in one year.
| Shares Outstanding | 643.40M |
| Shares Change (YoY) | -1.83% |
| Shares Change (QoQ) | -2.84% |
| Owned by Insiders (%) | 36.22% |
| Owned by Institutions (%) | 19.13% |
| Float | 409.31M |
Valuation Ratios
The trailing PE ratio is 25.35 and the forward PE ratio is 13.97.
| PE Ratio | 25.35 |
| Forward PE | 13.97 |
| PS Ratio | 2.11 |
| PB Ratio | 1.02 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.50, with an EV/FCF ratio of -15.11.
| EV / Earnings | 17.04 |
| EV / Sales | 1.42 |
| EV / EBITDA | 10.50 |
| EV / EBIT | 33.89 |
| EV / FCF | -15.11 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.65.
| Current Ratio | 1.61 |
| Quick Ratio | 1.47 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 9.95 |
| Debt / FCF | -14.32 |
| Interest Coverage | 1.60 |
Financial Efficiency
Return on equity (ROE) is 4.08% and return on invested capital (ROIC) is 0.88%.
| Return on Equity (ROE) | 4.08% |
| Return on Assets (ROA) | 0.77% |
| Return on Capital (ROIC) | 0.88% |
| Revenue Per Employee | 743,747 |
| Profits Per Employee | 61,877 |
| Employee Count | 10,939 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 5.95 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.84% in the last 52 weeks. The beta is 0.76, so Intco Medical Technology's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +24.84% |
| 50-Day Moving Average | 25.90 |
| 200-Day Moving Average | 24.31 |
| Relative Strength Index (RSI) | 50.68 |
| Average Volume (20 Days) | 20,342,748 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Intco Medical Technology had revenue of CNY 8.14 billion and earned 676.87 million in profits. Earnings per share was 1.04.
| Revenue | 8.14B |
| Gross Profit | 1.55B |
| Operating Income | 340.26M |
| Pretax Income | 681.38M |
| Net Income | 676.87M |
| EBITDA | 1.09B |
| EBIT | 340.26M |
| Earnings Per Share (EPS) | 1.04 |
Balance Sheet
The company has 16.56 billion in cash and 10.93 billion in debt, giving a net cash position of 5.64 billion or 8.76 per share.
| Cash & Cash Equivalents | 16.56B |
| Total Debt | 10.93B |
| Net Cash | 5.64B |
| Net Cash Per Share | 8.76 |
| Equity (Book Value) | 16.84B |
| Book Value Per Share | 25.75 |
| Working Capital | 7.44B |
Cash Flow
In the last 12 months, operating cash flow was 723.49 million and capital expenditures -1.49 billion, giving a free cash flow of -762.99 million.
| Operating Cash Flow | 723.49M |
| Capital Expenditures | -1.49B |
| Free Cash Flow | -762.99M |
| FCF Per Share | -1.19 |
Margins
Gross margin is 19.10%, with operating and profit margins of 4.18% and 8.32%.
| Gross Margin | 19.10% |
| Operating Margin | 4.18% |
| Pretax Margin | 8.38% |
| Profit Margin | 8.32% |
| EBITDA Margin | 13.46% |
| EBIT Margin | 4.18% |
| FCF Margin | -9.38% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.35%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.35% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.13% |
| Buyback Yield | 1.83% |
| Shareholder Yield | 2.18% |
| Earnings Yield | 3.95% |
| FCF Yield | -4.52% |
Stock Splits
The last stock split was on June 13, 2022. It was a forward split with a ratio of 1.2.
| Last Split Date | Jun 13, 2022 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Intco Medical Technology has an Altman Z-Score of 1.87. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.87 |
| Piotroski F-Score | n/a |